Advertisement

Topics

Novartis Oncology Company Profile

08:28 EDT 24th September 2017 | BioPortfolio


News Articles [1981 Associated News Articles listed on BioPortfolio]

Novartis Oncology plans acceleration of Russian expansion

Swiss pharma giant Novartis is considering accelerating expansion in the Russian market of anti-cancer…

Midatech signs deal with Novartis to investigate panobinostat to treat brain cancers

Midatech Pharma has inked a global licensing agreement with Novartis for the oncology compound panobinostat.

Novartis Beats CAR-T Competitors To The Pricing Punch With Kymriah Approval

Novartis got a leg up on its competition Aug. 30 with an earlier-than-expected approval for Kymriah in pediatric ALL, ending...   

Update: Novartis Takes on Blood Cancer with new Biosimilar Approval

Update (19/06/2017): The EMA has cleared Sandoz’ Rixathon, a biosimilar to rituximab, making it the second oncology biosimilar in the EU. Novartis’ fourth EMA-approved biosimilar is set t...

EU medicines agency recommends approval of Novartis leukaemia drug Rydapt

ZURICH (Reuters) - A European Medicines Agency (EMA) panel recommended on Friday approval of a new Novartis drug to be used against a tough-to-cure form of blood cancer as the Swiss drugmaker makes he...

Novartis: Dividendengarant mit Produktoffensive

Die Meldungen reißen derzeit beim Schweizer Pharmakonzern Novartis nicht ab. Zuletzt hat Novartis vielversprechende Studiendaten zu seinem Produktkandidaten AMG 334 (Erenumab) zur Behandlung von Mi.....

Novartis: Neue Impulse

Die Analysten von Kepler Cheuvreux bleiben bei der Kaufempfehlung für die Aktien von Novartis. Verändert wird hingegen das Kursziel für die Schweizer Aktie. Bisher lag dieses für die Novartis-Papi...

Novartis grants Oncology Venture an option to an undisclosed small molecule to treat cancer

Clinical Trials [478 Associated Clinical Trials listed on BioPortfolio]

Study to Collect and Assess Long-term Safety of Everolimus in Patients Who Are on Everolimus Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator.

The purpose of this study is to collect and assess long-term safety of everolimus in patients who are currently receiving everolimus treatment in a Novartis-sponsored, Oncology CD&MA study...

Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative

Countries throughout the world are facing a growing non-communicable disease (NCD) burden. In developing countries, medicines to treat NCDs are often difficult to access or too expensive f...

Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subject (Aged 6 to 72 Months) Versus Control Vaccines

This study will evaluate the safety, tolerability and immunogenicity of one or two 0.25mL or 0.5mL intramuscular injections of influenza vaccine compared with control vaccine in subjects 6...

Novartis Pandemic Influenza A (H1N1) Vaccine(s) Observational Comparative Safety Study

The primary objective of this observational, comparative safety study is to evaluate the safety of the Novartis Pandemic Influenza A (H1N1) vaccine in pregnant women and their off spring, ...

Safety, Tolerability and Immunogenicity of Three Doses of Novartis Meningococcal B Vaccine When Administered to Healthy At-risk Adults

This study is aimed to evaluate safety, tolerabilty and immunogenicity of three doses of Novartis Meningococcal B vaccine and of one dose of Novartis Menongococcal ACWY vaccine when adnmi...

Companies [759 Associated Companies listed on BioPortfolio]

Novartis Oncology

Novartis Consumer Health

Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innova...

Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG

Novartis AG

Novartis's name, derived from the Latin novae artes, means "new skills" and reflects Novartis's commitment to focus research and development to bring new healthcare products to the...

Novartis Vaccines and Diagnostics

Novartis Vaccines is a global leader in providing vaccines to protect against deadly meningococcal disease. Through industry-leading scientific expertise, the company is focused on extending critical ...

More Information about "Novartis Oncology" on BioPortfolio

We have published hundreds of Novartis Oncology news stories on BioPortfolio along with dozens of Novartis Oncology Clinical Trials and PubMed Articles about Novartis Oncology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Novartis Oncology Companies in our database. You can also find out about relevant Novartis Oncology Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record